This case is also compared with previous reports in the literature of patients with elevated serum levels of immunoreactive TSH in the presence of elevated total and free thyroid hormones. A classification of these cases, termed "inappropriate secretion of TSH," is proposed.
INTRODUCTION
Serum thyrotropin (TSH)1 is usually suppressed in clinical disorders associated with the hypersecretion of thyroid hormones, thyroxine (T4), and triiodothyronine (T3) (1) (2) (3) (4) . However, recently the combination of elevated serum TSH and thyroid hormones has been described in a few patients. Even this small group appears heterogeneous, since clinical features of the patients and proposed pathogenesis of the TSH hypersecretion differ. Hamilton, Adams, and Maloof (5), Faglia et al. (6) , O'Donnell, Hadden, Weaver, and Montgomery (7), and Mornex et al. (8) studied patients with pituitary tumors, hypersecretion of TSH and hyperthyroidism, while Hamilton and Maloof (9) described a similar patient who also had acromegaly. ' Refetoff, DeGroot, Benard, and DeWind (10, 11), Bode, Danon, Weintraub, Maloof, and Crawford (12) , and Lamberg (13) have described clinically euthyroid patients with elevated serum thyroid hormones and TSH who appear to have varying degrees of tissue resistance to the action of thyroid hormones and elevated serum TSH. More recently, Emerson and Utiger (14) reported a patient with hyperthyroidism and elevated serum TSH but without evidence of a pituitary tumor. In their case 1Abbreziations used in this paper: PBI, protein-bound the relatively autonomous TSH hypersecretion was thought to result from excessive pituitary stimulation by an endogenous releasing factor, possibly thyrotropin-releasing hormone (TRH).
In the patient described herein, hyperthyroidism appears to be caused by excessive thyroidal stimulation by TSH, which remains partially responsive to both normal stimulatory and inhibitory factors. The principal abnormality appears to be a selective resistance of the pituitary to suppression by thyroid hormones.
CASE REPORT S. F. (NIH 053533), a 7-yr-old white girl, was referred to the National Institutes of Health in December 1963, because of hyperkinesia, decreased attention span, and excessive sweating. She was the product of a normal gestation, weighed 5 lbs, 8 oz., and appeared entirely normal at birth, and attained her developmental milestones normally. Upon entering kindergarten she was found to have a learning disability, subsequently diagnosed as a specific dyslexia. Before her initial evaluation at the NIH, her only medical illness had been rubeola. There was no family history of thyroid disease. She was mildly hyperactive with a resting pulse rate of 110/ min, and her height was 117 cm (just over the 10th percentile). She weighed 17.6 kg (just below the 3rd percentile). She had widened palpebral fissures but no proptosis or lid lag. Her palms were warm and moist, and the deep tendon reflexes were hyperactive. The thyroid gland was soft, symmetric, nontender, and minimally enlarged. Protein-bound iodine (PBI) was 14.4 pg/dl ( 
METHODS
Serum TSH was measured by a double-antibody radioimmunoassay with a sensitivity of 0.5 /AU/ml of serum; the range of normal values was <0.5-3.5 ,U/ml with a mean of 1.7 iuU/ml (4) . Serum T4 was measured by competitive protein-binding analysis (15) , and serum Ts (16) and prolactin (17) were measured by radioimmunoassay. A variety of other hormone measurements and endocrine tests were performed by previously published methods (see references, Table II ). TRH, 500 gg, was injected rapidly i.v., and blood was collected at -10, 0, 15, 20, 30, 45, 60, 120, and 180 min for measurement of TSH and at 0, 60, and 180 min for Ts. The peak TSH response in normals was 5-30 pU/ml; in hyperthyroid patients with Graves' disease, toxic multinodular goiter, or toxic adenoma, there was no TSH response detected, as previously reported (2) (3) (4) . RESULTS Base-line studies. Basal thyroid function studies are outlined in Table I . All measurements of thyroid hormones were elevated (T4 was 12.7,ug/dl, free T4 was 2.7 ng/dl, Ts was 220 ng/dl), and the binding proteins were normal (thyroxine-binding globulin capacity was 19 ug of T4/dl). The TSH was not only absolutely elevated (9.3 gU/ml), but was particularly inappropriate relative to the elevated thyroid hormone levels normally associated with suppressed TSH (< 0.5 uU/ml) (1-4). Thyroidal hyperactivity was shown by elevated 'I uptake (4-h was 26%, 24-h was 43%) and [181I] PBI (0.14% of dose/liter at 48 h). Peripheral hyperthyroidism, that is excessive effect of thyroid hormone on peripheral tissues, was documented by elevated BMR of + 20% (18), shortened pulse-wave arrival time (QKd interval) of 135 ms (19) , and elevated red cell sodium content of 9.4 mmol/liter of cells (20) .
Stimulation by TRH on day 2 ( Fig. 1 The integrity of secretion of the other anterior pituitary hormones and their effectiveness at their respective target organs were studied both in the basal state and after provocative stimuli (22-24, clined from 9.3 to 2.0 AU/ml (Fig. 2) . The serum T8 was probably much higher than this minimal level through most of the day (25) . The thyroidal response to the lowered circulating TSH concentration was manifested by a decline in the uptake of radioiodine at 4 h from 26 (26) . longed clinical course and apparently normal pituitary size, as documented by careful tomography of the sella turcica and full visual fields. However, although to our knowledge a microadenoma of the pituitary associated with high serum TSH has never been described, we cannot definitely exclude this possibility. This is especially true since the natural history of clinically undetectable pituitary microadenomas, for example, those associated with hyperprolactinemia and surgically proved (33) , is unknown. A nonpituitary tumor producing TSH ectopically is also unlikely; the prolonged clinical course in this young woman is against neoplasia. Moreover, TSH responsiveness to both stimulation and suppression argues for a pituitary rather than an ectopic origin. General target organ resistance to the action of thyroid hormone is ruled out by the demonstrated increase in peripheral tissue effects of thyroid hormone in the base-line state. Our patient like the patient reported by Emerson and Utiger, therefore, is an example of the syndrome of nonneoplastic hypersecretion of TSH and hyperthyroidism.
Our patient and the one reported by Emerson and Utiger, although apparently presenting similar clinical syndromes, demonstrate several important differences. Their patient had originally presented a more usual picture of toxic diffuse goiter with suppressed pituitary TSH, and only after a period of radioiodine-induced hypothyroidism did the serum TSH concentration become inappropriate for the level of circulating thyroid hormones. In our patient, the TSH level was inappropriately high even before subtotal thyroidectomy in 1969. However, we cannot prove that thyroidal overstimula-tion by TSH was the initial cause of our patient's hyperthyroidism. At the time of study, the patient reported by Emerson In our case the cause of the TSH hypersecretion appears to be a selective resistance of the pituitary to the action of thyroid hormone. Interestingly, this resistance may not be confined to thyrotrophs but may also be shared by somatotrophs and lactotrophs. Although the patient's serum growth hormone and prolactin were normal in the basal state, both hormones showed increased responses to provocative stimuli. These increased responses were particularly striking in view of the elevated serum thyroid hormones, shown in certain instances to blunt the growth hormone response to hypoglycemia (35) as well as the prolactin response to TRH (22) in humans. Moreover, neoplastic rat pituitary cell lines that secrete both prolactin and growth hormone in vitro have been shown to have highaffinity nuclear receptors for thyroid hormone (36) .
The pituitary resistance to thyroid hormone in this patient was only partial, since the TSH responded to both stimulatory and suppressive factors as in patients with primary hypothyroidism. Specifically, there was an exaggerated TSH response to exogenous TRH stimulation, blunting of the TSH response to TRH by thyroid hormone, and blunting of basal TSH but not of TRH-stimulated TSH secretion by dexamethasone. However, unlike patients with primary hypothyroidism (or normals) our patient achieved a normal basal TSH and response to TRH only with markedly elevated serum Ts levels. In fact, we have not yet determined what dose of thyroid hormone would be required to suppress both basal and TRH-responsive TSH totally. As described above, these data are not compatible solely with hypersecretion of endogenous TRH. This syndrome is, therefore, functionally analogous to Cushing's disease, in which there is a qualitatively normal but quantitatively abnormal response of ACTH to glucocorticoid suppression. However, the histopathology of the pituitary as well as the biochemical basis for resistance to thyroid hormone in this disorder remain to be elucidated.
